SCHEMBL20109243

SCHEMBL20109243

C=C(C(C)C)P1(=N)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.32
CYP2D6 P10635 2/20 0.32
ALDH1A1 P00352 2/20 0.31
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GFER P55789 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.31
ATM Q13315 1/20 0.31
TAAR1 Q96RJ0 1/20 0.30
CYP3A4 P08684 1/20 0.30
ALOX15 P16050 1/20 0.30
CHRNB2 P17787 1/20 0.30
NFKB1 P19838 1/20 0.30
MAPK1 P28482 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA7 P36544 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109250 0.86 CYP2D6 (0.36) CYP2D6ALDH1A1ADRA2AADRA2CKDM4E
SCHEMBL20109215 0.80 ATM (0.33) CYP2D6ALDH1A1KDM4EGFERL3MBTL1
SCHEMBL20109134 0.80 DHODH (0.33) CYP2D6ALDH1A1KDM4EGFERL3MBTL1
SCHEMBL20113538 0.79 ALDH1A1 (0.39) ALDH1A1LMNATSHR
SCHEMBL20109240 0.77 CHRNA7 (0.36) SIGMAR1ADRA2AADRA2BADRA2CCYP3A4
SCHEMBL20109256 0.75 ALDH1A1 (0.41) ALDH1A1L3MBTL1TSHRATM
SCHEMBL20113632 0.73 MMP8 (0.47) ALDH1A1KDM4ETSHR
SCHEMBL20113547 0.72 MMP8 (0.49) ALDH1A1GFERL3MBTL1TSHR
SCHEMBL20109238 0.71 TRPA1 (0.32) SIGMAR1ALDH1A1ADRA2AADRA2BADRA2C
SCHEMBL20113534 0.71 OPRD1 (0.36) ALDH1A1L3MBTL1LMNATSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 SIGMAR1 2527/4885CYP2D6 3429/4885ALDH1A1 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.